|
|
|
01.02.26 - 07:06
|
OTC Sales of Emergency Contraception to Start in Japan Mon. (Nippon)
|
|
|
Tokyo, Feb. 1 (Jiji Press)--Over-the-counter sales of an emergency contraceptive pill, aimed at preventing unwanted pregnancy, are set to start in Japan on Monday. The pill, Norlevo from Daiichi Sankyo Healthcare Co., has a suggested retail price of 7,480 yen per tablet. Taking one pill within 72 hours of sexual intercourse can prevent pregnancy with a probability of about 80 pct. In Jap......
|
|
|
|
|
|
|
|
|
22.01.26 - 07:36
|
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe (Business Wire)
|
|
|
TOKYO & MUNICH--(BUSINESS WIRE)--Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe.
Dr. Jürgen Müller will retire after nearly 30 years of research work at Daiichi Sankyo. Under his leadership, the Translational Research Center Europe, previously called the Tissue and Cell Research Center Munich, has grown from three to 40 researchers since it was founded in 1997 and has become an internationally recognized institution that plays a strategic role in the global innovation process of Daiichi Sankyo.
Dr. Veronika Rozehnal joined Daiichi Sankyo in 2009 and has held various positions at the Translational Research Center Europe in addition to spending three years at the Daiichi Sankyo R&D Center in Tokyo. Dr. Rozehnal graduated from Ernst-Moritz-Arndt University of Greifswald, Germany with a Ph.D. degree in Clinical Pharmacology.
“Jürgen Müller has made significant scientific contributions that have ...
|
|
|
|
|
21.01.26 - 08:00
|
Research: Bernstein Lists Top Picks in Asia-Pacific for 1H26 (Table) (AAStocks)
|
|
|
CNOOC (00883.HK)JD.com (JD.US) (09618.HK)SK hynix (000660.KS)Samsung Electronics (005930.KS)Tokyo Electron (8035.JP)Kokusai (6525.JP)Renesas (6723.JP)Power Finance (POWF.IN)Record plc (RECL.IN)Daiichi Sankyo (4568.JP)Eisai Co (4523.JP)Rio Tinto (RIO.AU)Piotech (688072.SH)MediaTek (2454.TW)Tianqi Lithium (002466.SZ) (09696.HK)Doo......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.12.25 - 08:31
|
Enhertu granted BTD for post-neoadjuvant early BC (Cision)
|
|
|
22 December 2025
Enhertu granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer
Tenth Breakthrough Therapy Designation for AstraZeneca and Daiichi Sankyo's Enhertu with the latest based on DESTINY-Breast05 Phase III trial results
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer with residual invasive disease in the breast and/or axillary lymph nodes after neoadjuvant...
|
|
|
18.12.25 - 08:48
|
Japan to Start OTC Sales of Emergency Contraception in Feb. (Nippon)
|
|
|
Tokyo, Dec. 18 (Jiji Press)--Daiichi Sankyo Healthcare Co. said Thursday that it will start over-the-counter sales of an emergency contraceptive pill in Japan on Feb. 2, marking the first time in the country that such a pill will be sold without a prescription. There will be no age limit for purchasing the drug, Norlevo. For safety purposes, the pill must be taken in the presence of a train......
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
